Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Glycerine Magnesium sulphate paste

Group S: sugammadex injection

Guben Kechuan Granules group

Guideline-directed medical therapy

HCV+PWID

HFMS, MRC, ACTIVLIM, PedsQl-4.0

HIV self test

HPV Self-Collection

High Dose GGQL Decoction

Huangqi Guizhi Wuwu decoction

Hydroxychloroquine Sulfate 200 MG [Plaquenil]

Hypofraction radiation

Hypofractionated Radiation Therapy

Hypofractionated radiotherapy

Immune-enhancing nutritional beverage

Inactivated influenza vaccine

Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)

Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

Induction therapy-Pro regimen

Infrared thermography

Inhaled corticosteriod/long-acting beta-agonist plus Montelukast

Insulin Aspart Injection（UBLIN®）

Intra-arterial administration of neuroprotective agents

Frequently asked questions